Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: A randomized controlled study

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 1, 2002, Pages 33-39

  Madsen, Jonna S ^a   Kristensen, Søren R ^a   Klitgaard, Niels A ^a   Bladbjerg, Else M ^b   Abrahamsen, Bo ^a   Stilgren, Lis ^a   Jespersen, Jørgen ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Homocysteine; Hormone replacement therapy; Methylenetetrahydrofolate reductase; Randomized controlled trial

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036071278     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.123030     Document Type: Article

References (25)

1. Homocysteine and cardiovascular disease
2. Homocysteine and risk of cardiovascular disease among postmenopausal women
3. Population variation and genetics of plasma homocyst(e)ine level
4. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years
5. Increased plasma homocysteine after menopause
6. Cortisol and estradiol: Nongenetic factors for hyperhomocyst(e)inemia
7. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey
8. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
9. Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels
10. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women
11. Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women
12. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
13. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women
14. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women
15. Plasma homocysteine in women taking hormone replacement therapy: The postmenopausal estrogen/progestin interventions (PEPI) trial
16. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels
17. The Danish Osteoporosis Prevention Study (DOPS): Project design and inclusion of 2000 normal perimenopausal women
18. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin snpplementation
19. Homocysteine in plasma: Stabilization of blood samples with fluoride
20. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
21. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
22. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects
23. Hormone replacement therapy and cobalamin status in elderly women
24. Hormone replacement therapy and plasma homocysteine levels
25. Cardiovascular disease risk and hormone replacement therapy (HRT): A review based on randomized, controlled studies in postmenopausal women